Source: New Scientist
Date: 13 June 2007
Summary:
Researchers at the annual meeting of the American Society of Gene Therapy report progress in targeting gene therapy to stem cells in order to treat fatal neurodegenerative conditions known as lysosomal storage diseases:
"Clinical trials are on the horizon for treatments for diabetes and a group of fatal neurodegenerative conditions called lysosomal storage diseases. Meanwhile, gene therapists are also using their skills to make "improved" stem cells for regenerative therapies (see "Stem cell enhancement")."
